Research Keyword: Protein phosphorylation

rFIP-GMI Suppresses IGF-1–Induced Invasion and Migration in Breast Cancer Cells via PI3K/Akt/β-Catenin Inhibition

Researchers found that a protein from a medicinal mushroom called Ganoderma microsporum can fight aggressive breast cancer by blocking a cellular pathway that helps cancer cells spread. The protein works by stopping the activation of key molecules (PI3K and Akt) that cancer cells use to invade surrounding tissues and migrate to other parts of the body. By blocking this pathway, the mushroom protein also prevents another molecule called β-catenin from entering the cell nucleus, where it would trigger genes that promote cancer growth and spread.

Read More »

Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis

Eumycetoma is a serious fungal infection that causes large tumors under the skin and is very difficult to treat. Scientists used computer analysis to find special proteins called kinases in the fungus that might be good targets for new drugs. They discovered that proteins involved in the fungus’s cell wall are promising targets, which could lead to better treatments for this neglected disease.

Read More »

Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration

Researchers discovered that a specific protein called GAP-43 plays a crucial role in protecting brain cells from damage caused by α-synuclein, a protein involved in Parkinson’s Disease. When GAP-43 is modified through a process called phosphorylation at certain sites, it promotes the growth of neurites (neural connections) and formation of healthy synapses. The drug FK506, already approved by the FDA, appears to work by controlling this phosphorylation process, offering potential therapeutic benefits for Parkinson’s patients.

Read More »
Scroll to Top